CLINICAL_TRIALS
trial_result
· 2023-10-10
Clinical Trial Update: Neoadjuvant Pembrolizumab Plus Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Summary
Phase 2 trial update on neoadjuvant pembrolizumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking Union Medical College Hospital | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED